Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GOLCADOMIDE Cause Diffuse large b-cell lymphoma refractory? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Diffuse large b-cell lymphoma refractory have been filed in association with GOLCADOMIDE. This represents 20.0% of all adverse event reports for GOLCADOMIDE.

6
Reports of Diffuse large b-cell lymphoma refractory with GOLCADOMIDE
20.0%
of all GOLCADOMIDE reports
0
Deaths
0
Hospitalizations

How Dangerous Is Diffuse large b-cell lymphoma refractory From GOLCADOMIDE?

Of the 6 reports.

Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GOLCADOMIDE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does GOLCADOMIDE Cause?

Diffuse large b-cell lymphoma recurrent (6) Febrile bone marrow aplasia (5)

What Other Drugs Cause Diffuse large b-cell lymphoma refractory?

RITUXIMAB (461) CYCLOPHOSPHAMIDE (360) DOXORUBICIN (345) VINCRISTINE (331) ETOPOSIDE (244) PREDNISONE (214) EPCORITAMAB-BYSP (198) CYTARABINE (193) DEXAMETHASONE (170) CISPLATIN (156)

Related Pages

GOLCADOMIDE Full Profile All Diffuse large b-cell lymphoma refractory Reports All Drugs Causing Diffuse large b-cell lymphoma refractory GOLCADOMIDE Demographics